Quest diagnostics to acquire pathai diagnostics to accelerate ai and digital pathology adoption in cancer diagnosis; forms licensing agreements with pathai

Transaction is part of wide-ranging collaboration to combine quest's oncology expertise and scale with pathai's ai and digital pathology innovations to speed diagnosis, improve quality and reduce costs secaucus, n.j. and boston , may 1, 2024 /prnewswire/ -- quest diagnostics (nyse: dgx), a leader in diagnostic information services, and pathai, a global provider of artificial intelligence-powered technology for pathology, today announced a multi-faceted collaboration designed to accelerate the adoption of digital and ai pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.
DGX Ratings Summary
DGX Quant Ranking